Steps to Better Cardiovascular Health: How Many Steps Does It Take to Achieve Good Health and How Confident Are We in This Number? by Tudor-Locke, Catrine
Steps to Better Cardiovascular Health: How Many Steps
Does It Take to Achieve Good Health and How Confident
Are We in This Number?
Catrine Tudor-Locke
Published online: 30 April 2010
# The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract Pedometers and other types of step-counting
devices are growing in popularity with both researchers
and practitioners. The focus of this article is on describing
the most recent pedometer-related advances in terms of
cardiovascular health. The emergent body of evidence
suggests that pedometer-determined physical activity is
related to a number of cardiovascular health outcomes and
that intervention participants can realize modest changes in
body mass index and blood pressure. Taking into consid-
eration individual baseline values, tailored messages con-
gruent with public health recommendations should promote
incremental increases in steps/day on the order of an extra
3,000 to 4,000 (approximately 30 min) of at least moderate
intensity and taken in at least 10-minute bouts. Additional
health benefits accrue with greater increases. Of course,
even more benefits are possible from engaging in vigorous
physical activity, but this seems less appealing for most
people. Pedometer-based guidelines are not intended to





With the release of its first-ever evidence-based physical
activity guidelines report in 2008, the US government
confirmed the very strong scientific evidence that continues
to show that physically active people have higher levels of
health-related fitness, a lower risk profile for developing a
number of disabling medical conditions (including cardio-
vascular diseases), and lower rates of various chronic
diseases than do people who are not active [1￿￿]. Further,
they concluded that some physical activity is better than
none, that additional health benefits accrue with greater
volumes of physical activity, and that even more benefits
may be had from participating in vigorous physical activity
[1￿￿]. Because US adults average less than 2 min/d of
vigorous physical activity [2￿], it stands to reason that the
greater focus should be placed on increasing overall
physical activity levels. Of all types of physical activity,
walking stands out as the most popular form of leisure time
exercise [3￿], can be easily performed at moderate intensity
[4], and is also a functional part of activities of daily living.
Armed with such information, clinicians and other
practitioners represent frontline forces to motivate patients
to realize the multiple and profound benefits of a physically
active lifestyle. Among our arsenal, and growing in
acceptance, is the simple and inexpensive pedometer,
especially when imbedded as a motivational tool in an
intervention program. In support of the efficacy of
pedometer-based programming, at least two systematic
reviews have catalogued positive effects on walking
behaviors and some cardiovascular risk factors, including
weight loss [5￿￿, 6￿￿] and systolic blood pressure [5￿￿].
Clinical applications for pedometers include screening,
prescription, monitoring, feedback, and evaluation. To
nurture increased confidence in uptake of such technology,
the focus of this article is to describe the most recent
pedometer-related advances in terms of cardiovascular
health. In particular, I attempt to lay the background
information necessary to answer “how many steps does it
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How Are Steps Measured?
Pedometers are typically waist-mounted instruments that
vary in terms of cost and internal measurement mecha-
nisms. There are generally two types of electronic ped-
ometers on the market today: 1) a traditional version that
detects steps taken using a spring-suspended horizontal
lever arm, and 2) a newer version that contains a
piezoelectric accelerometer. Both respond to vertical accel-
erations (ie, up and down motions) of the hip. The
piezoelectric pedometers often have a memory storage
feature (data from multiple days can be held in memory)
and they may also offer an option to separately record only
those steps that meet a minimum force threshold marketed
as congruent with activity of at least moderate intensity.
More advanced accelerometers such as those used in the
National Health and Nutrition Examination Survey
(NHANES) [7￿￿] can provide additional information on
time spent in different intensities of activity, but this usually
is much more expensive technology that also requires
additional time and expertise to successfully distill [8￿￿].
Additionally, these accelerometers are known to be sensi-
tive to low-force accelerations [7￿￿]. Subsequently, their
inflated step output also represents erroneous steps and
therefore needs to be manipulated to make them more
comparable to commonly used research-grade pedometers
(that are more likely to be used in clinical applications)
[7￿￿]. A more detailed comparison of different types of
available instruments is published elsewhere [8￿￿].
The most appropriate output from pedometers is the
simple step taken [9]. In contrast, distance walked or energy
expenditure are variables derived from manipulations of the
raw step data, and these have been shown to produce
additional layers of measurement error [10]. Pedometers
recognize ambulatory activity, but their design (and that of
other types of waist-mounted objective monitors) makes
them unable to detect additional energy expended in
climbing stairs, walking up hill, carrying loads, or other
arm activities. Pedometers and other types of objective
monitors cannot be used in water conditions (and therefore
they cannot detect swimming) and they generally do not
capture bicycling movements since the hips do not typically
move up and down with enough force to generate step
counts. Participation in these types of nonambulatory
activities is relatively infrequent on a population level
[3￿]; however, when using pedometers for clinical purposes
(eg, in interventions), a conversion factor to account for
more frequent individual participation appears to be prudent
[11].
Unfortunately, the various available instruments detect a
“step” somewhat differently based on their own unique
design and measurement properties. For example, sensitiv-
ity might be controlled by coiled or hair springs or internal
microprocessors that innately differ between commercial
products [8￿￿]. Regardless, outputs are reasonably compa-
rable between studies and populations when high-quality,
research-grade pedometers are used [7￿￿].
Are Steps Related to Cardiovascular Health Outcomes?
A systematic review assembled cross-sectional studies
describing relationships between pedometer-determined
step data and various cardiovascular risk factors. A weak
inverse relationship was evident with both body mass index
(BMI) and percentage overweight (median r=−0.27 and r=
−0.22, respectively) [12]. Relationships with fitness ranged
from weak to moderate depending on measure studied:
6-minute walk test (median r=0.69), timed treadmill test
(median r=0.41), and estimated maximum oxygen uptake
(median r=0.22). Self-reported participation in vigorous
physical activity and accumulated steps/day has been
independently and positively related to enhanced heart rate
response to submaximal exercise [13]. More recently,
Japanese researchers have developed a model to predict
VO2 max in adult women from pedometer-determined
steps/day, age, and BMI that correlates well (r=0.81) with
measured VO2 max [14￿] .S c h m i d te ta l .[ 15￿]h a v e
demonstrated that individuals taking ≥5,000 steps/day had
substantially lower prevalence of adverse cardiometabolic
health indicators than those taking lower amounts. Further,
individuals taking ≥12,500 steps/day had the best profiles
compared with those taking lower amounts. Even in
chronically ill populations, typically considered sedentary
to low active, steps/day correlates with fitness, centrally
distributed adiposity, and high-density lipoprotein cholesterol
[16￿]. Reduced pedometer-determined physical activity is a
strong predictor of death in chronic heart failure, possibly
surpassing traditional laboratory-based exercise tests [17].
Pedometer-determined physical activity has also been asso-
ciated with better brachial artery flow-mediated dilation
among individuals with peripheral arterial disease [18￿].
As mentioned previously, systematic reviews have
assessed the pedometer-intervention literature and have
reported overall changes in steps/day [5￿￿, 6￿￿], BMI [5￿￿,
6￿￿], and blood pressure [5￿￿]. Specifically, intervention
participants increased their steps/day on average by approx-
imately 2,500 [5￿￿], achieved modest weight losses (approx-
imately 0.05 kg per week on intervention) [6￿￿], and
decreased their systolic blood pressure by 3.8 mm Hg
[5￿￿]. Most of these pedometer-based interventions have
focused on relatively short-term changes in outcomes over 4
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studies that lasted 1 year or more [19, 20]. Sugiura et al.[20￿]
collected 2 years of pedometer data on 14 menopausal
women who were instructed to attend a 90-minute physical
education class once a week and increase their steps/day by
2,000 to 3,000 steps over baseline. Significant improvements
were observed in serum lipids (total cholesterol, high-density
lipoprotein cholesterol, and their ratio). Miyatake et al. [19]
followed 31 Japanese men who were instructed to increase
their daily steps. Visceral adipose tissue was reduced, and
daily walking expressed as steps/day was found to be a
greater predictor of its reduction compared with changes in
exercise capacity at a 1-year examination. McTiernan et al.
[21￿] conducted a year-long exercise trial that used pedom-
eters for measurement purposes (not for motivational
purposes). They reported that participants who achieved the
greatest incremental changes in steps/day assessed at
12 months from baseline also realized the greatest improve-
ments in weight, hip circumference, BMI, body fat, and
intra-abdominal fat. There is a strong negative relationship
between study duration and resulting weight loss [6￿￿],
indicating that benefits are potentiated with prolonged
adherence.
How Many Steps Do People Normally Take?
In terms of normative data, recent US estimates indicate
that typical modern adult values are between 5,900 and
6,900 steps/day [7￿￿, 22, 23]. In contrast, traditional Amish
women and men (who reject a modern lifestyle) take
14,000 to 18,000 steps/day [24]. The stark discrepancy in
these two sources of normative data suggest that contem-
porary living negatively impacts physical activity levels,
but it does not clearly answer dose-response questions.
How Many Steps Are Equivalent to Public Health
Recommendations?
Public health recommendations state that, for substantial
health benefits, adults should accumulate 150 min/wk of at
least moderate intensity activity, or 75 min/wk of vigorous
intensity activity. It is possible to translate these recom-
mendations in terms of pedometer-determined step data. A
cadence of approximately 100 steps per minute is consid-
ered the floor value for moderate intensity activity (ie, at
least 3.0 metabolic equivalents [METs]) [25￿￿, 26], and
approximately 130 steps per minute is congruent with
vigorous intensity activity (ie, at least 6.0 METs) [26].
Using simple arithmetic, these time-based recommenda-
tions can be translated as 15,000 steps per week in
moderate-intensity activity (or 3,000 steps/day for 30 min
for 5 days) or 9,750 steps per week (or 3,250 steps/day for
25 min for 3 days) in vigorous-intensity activity. To be truly
consistent with public health recommendations, however,
these steps should be accumulated in bouts of at least
10 min and preferably spread out throughout the week
[27￿￿]. Importantly, the unstated implication is that these
steps should be taken over and above some otherwise
undeclared baseline level of activity.
If we consider normative data (ie, 5,900–6,900 steps/
day) as indicative of baseline levels of activity, then simply
adding step-based translations results in a value of 8,900 to
9,900 steps/day (to be taken over 5 days in 1 week, for
example), of which at least 3,000 should meet moderate
intensity and bout requirements. Applying the same logic,
achieving 9,150 to 10,150 steps/day on at least 3 days of
the week by adding at least 3,250 steps/day taken at
vigorous intensity (and in at least 10 min bouts) also
conforms to public health recommendations. Combinations
of moderate and vigorous intensity performed at varying
frequencies during the week provide endless opportunities
for accumulating healthy physical activity. The advantage
of such multiple options is that they fit well within accepted
theoretical notions underlying approaches to individualize
successful behavior change [28].
Studies that have concurrently collected data on time in
intensity and steps have shed light on the relationship
between these two outputs. For example, a recent interpre-
tation of NHANES accelerometer data using pedometer-
based scales indicated that those who achieve between
7,500 and 9,999 steps/day also average approximately
30 min of moderate-to-vigorous physical activity, and those
who achieve between 10,000 and 12,499 steps/day average
approximately 60 min of moderate-to-vigorous physical
activity [29￿￿]. As additional confirmation, a dose-response
study in postmenopausal women demonstrated that those
who averaged approximately 7,500 steps/day achieved the
equivalent of public health recommendations for physical
activity energy expenditure [30]. As steps/day increases,
time spent in activity that is of at least moderate intensity
also increases; a measure of pedometer-determined steps/
day explains approximately 63% of time spent in moderate-
intensity activity [29￿￿]. The reason this cannot also be said
of vigorous activity is only because this behavior is so rare
on the population level [2￿, 29￿￿]. However, on an
individual level, exercise remains a prominent strategy for
increasing steps/day [31].
Is There a Simpler Way of Conveying Step Guidelines
for Physical Activity?
Obviously the combinations and permutations of volume,
intensity, days of the week, bout length, and so forth can
Curr Cardio Risk Rep (2010) 4:271–276 273become cumbersome when trying to provide clear guidance
to patients. In 2004, Tudor-Locke and Bassett Jr. [32]
established preliminary pedometer-determined physical
activity cut-points for healthy adults: 1) <5,000 steps/day
(sedentary); 2) 5,000 to 7,499 steps/day (low active); 3)
7,500 to 9,999 steps/day (somewhat active); 4) ≥10,000 to
12,499 steps/day (active); and 5) ≥12,500 steps/day (highly
active). These categories were reinforced in 2008 [33￿￿],
and in 2009 the original sedentary level was further spliced
into two additional levels: <2,500 steps/day (basal activity)
and 2,500 to 4,999 steps/day (limited activity) [7￿￿]. This
hierarchical approach (Fig. 1) to presenting pedometer-
determined physical activity also fits within motivational
stage-based schemes by considering individual baseline
levels of activity and conveying the dose-response nature of
participating in incrementally more and more physical
activity. Each of these mounting doses represents a
2,500-step increment over the previous dose. It is approx-
imately equal to 20 to 25 min of physical activity [26] and
is the amount that pedometer-based interventions typically
elicit [5￿￿]. Expressed another way, and considering, for
example, a baseline of 5,000 steps/day, 7,500 steps/day
would represent a 50% increase, and 10,000 steps/day a
100% increase. As noted previously, some physical activity
is better than none, and additional health benefits accrue
with greater volumes of physical activity [1￿￿]. Depending
on the specific outcome of interest, evidence suggests that
the greatest “bang for the buck” occurs when motivating
the most inactive individuals to increase their physical
activity by even a single stage [34]. Diminishing relative
returns would be expected with similar absolute increments
added to higher levels of activity. Of course, at all stages,
everyone should be encouraged to take these extra steps at
least moderate intensity and in minimal 10-minute bouts.
Even more benefits are possible by supplementing with
vigorous physical activity [1￿￿].
How Confident Are We About All This?
There are a number of things I am concerned about with
regard to objective monitoring of physical activity as a
whole [35￿]. Objective monitors, whether pedometers or
accelerometers, are commercial items and favorite models
disappear and new ones appear sporting additional value-
added features at regular intervals. This makes comparison
between studies and populations using different instrumen-
tation challenging. Further, although manufacturers may
claim that new models are “fully backwards translatable,”
contrary evidence is emerging [36￿, 37￿]. Technological
advances should be embraced, but measurement standard-
ization would assure us that what is detected as a step today
will remain so into the future. Unfortunately, manufac-
turers’ measurement technology is patent-protected and this
forces competitors to develop alternative approaches, so a
solution to the problem is not readily at hand. There is no
authoritative body at this time that requires standardization
of outputs or otherwise oversees quality control. The
ramification is that what is labeled a step by one instrument
is not necessarily the same thing as another instrument. The
measurement of steps is not the only output affected; the
same goes for objectively monitored time spent in
moderate-to-vigorous physical activity and sedentary
behaviors as well. Further, the race to market increasingly
sensitive instrumentation produces an inevitable specificity
tradeoff that results in the detection of more spurious steps.
Such heightened sensitivity undermines efforts to focus on
the benefits of higher-intensity walking. The fact that
research grade pedometers “fail” to detect very slow steps
can actually be considered a design feature that can be used
to effectively prod users to walk at higher speeds [38￿￿].
I will be the first to argue that we should not be
interpreting a “step” overly precisely. It is difficult to detect
differences in individuals who differ by less than 500 steps/
day (approximately equivalent to a 5-minute difference in
activity) and possibly by less than 1,000 steps/day. It is
more appropriate to speak in terms of step ranges. So, 3,000
to 4,000 steps is more realistic in terms of communicating
the amount taken in 30 min of moderate-intensity walking,
allowing for individual variation [25￿￿, 26]. And 7,500 to
9,999 steps/day corresponds to a category labeled as
somewhat active [32, 33￿￿] that represents increasing the
likelihood of achieving minimal public health requirements
for physical activity [7￿￿, 30, 39].
Current public health recommendations are based on
years of accumulated evidence. Pedometer-based guidelines Fig. 1 Step-defined physical activity hierarchy
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supplement it. Pedometers are simply another tool in our
arsenal. However, like all tools, knowledge of how best to
use them is imperative and can optimize their effectiveness.
The growing knowledge base includes recent systematic
reviews [5￿￿, 6￿￿] that provide expected change data
necessary for comparison and interpretation purposes,
updates on methodologic considerations useful for guiding
screening and monitoring [8￿￿], and an assemblage of
behavioral factors related to successfully increasing phys-
ical activity in pedometer-based interventions [38￿￿].
Conclusions
In summary, promoting increased walking behaviors is
consistent with public health recommendations. Pedometers
and other step counters are useful tools that can be used for
screening, prescription, monitoring, feedback, and evalua-
tion purposes. The emergent body of evidence suggests that
pedometer-determined physical activity is related to a
number of cardiovascular health outcomes. In particular,
intervention participants can realize modest changes in BMI
and blood pressure with increases of physical activity.
Further, continued participation appears to elicit accrued
benefits. US adults currently take approximately 5,900 to
6,900 steps/day. Taking this as indicative of baseline levels,
step-based translations of public health recommendations
suggest that US adults should be taking 8,900 to 9,900
steps/day on 5 days of the week for example, at least 3,000
of which should meet moderate intensity and bout require-
ments. Alternatively, they can also meet guidelines by
achieving 9,150 to 10,150 steps/day on at least 3 days of
the week by adding at least 3,250 steps/day taken at
vigorous intensity and in at least 10-minute bouts. Because
baseline levels of physical activity actually vary more
widely in individuals, tailored messages should promote
incremental increases in steps/day on the order of 3,000 to
4,000 extra steps/day (approximately 30 min), again of at
least moderate intensity and in at least 10-minute bouts. Not
only is this increment congruent with public health guide-
lines, it also encourages moving up at least one stage, if not
two, when applied to the stage-based pedometer step
hierarchy described here. Of course, even more benefits
are possible from engaging in vigorous physical activity,
but this seems less appealing for most people. Pedometer-
based guidelines are not intended to supplant existing
public health recommendations, but rather supplement
them.
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